In our previous study, control diet-fed AD males displayed attenuated weight gain and adiposity compared to wild-type (WT) controls and AD females, as well as reduced blood glucose levels following a glucose challenge, accompanied by increased expression of pro-inflammatory markers (Iba1, GFAP, TNF-α, and IL-1β) in the hypothalamus. Here, GFAP is linked to Alzheimer disease.